US CDC approves recommendations for chikungunya vaccines
Corrects dateline to May 21 May 21 (Reuters) - The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya, a mosquito-borne virus. The recommendations were approved on May 13, 2025, and are now official recommendations of the CDC. (Reporting by Sneha S K in Bengaluru; Editing by Vijay Kishore) ((Sneha.SK@thomsonreuters.com;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline